• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study
 
  • Details
  • Full
Options
2016
Journal Article
Title

Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study

Title Supplement
Abstract
Author(s)
Behrens, F.
Rossmanith, T.
Koehm, M.
Alten, R.
Aringer, M.
Burmester, G.R.
Feist, E.
Krüger, K.
Müller-Ladner, U.
Rubbert-Roth, A.
Wassenberg, S.
Tony, H.P.
Kellner, H.
Backhaus, M.
Burkhardt, H.
Journal
Arthritis & rheumatology  
Conference
American College of Rheumatology/Association of Reproductive Health Professionals (ACR/ARHP Annual Meeting) 2016  
Language
English
Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie IME  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024